Research Output per year
Fingerprint Dive into the research topics where David Cornblath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Medicine & Life Sciences
Peripheral Nervous System Diseases
Medicine & Life Sciences
Guillain-Barre Syndrome
Medicine & Life Sciences
Polyneuropathies
Medicine & Life Sciences
Intravenous Immunoglobulins
Medicine & Life Sciences
Neural Conduction
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Diabetic Neuropathies
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1973 2019
Chemotherapy-induced peripheral neurotoxicity: Facts, needs and future directions
Cavaletti, G. & Cornblath, D. R., Oct 1 2019, In : Journal of the Peripheral Nervous System. 24, S2, p. S86-S87Research output: Contribution to journal › Editorial
Drug Therapy
Direction compound
Current treatment practice of Guillain-Barré syndrome
IGOS Consortium, Jul 2 2019, In : Neurology. 93, 1, p. e59-e76Research output: Contribution to journal › Article
Miller Fisher Syndrome
Therapeutics
Plasma Exchange
Intravenous Immunoglobulins
Bangladesh
Diagnosis and management of Guillain–Barré syndrome in ten steps
Leonhard, S. E., Mandarakas, M. R., Gondim, F. A. A., Bateman, K., Ferreira, M. L. B., Cornblath, D. R., van Doorn, P. A., Dourado, M. E., Hughes, R. A. C., Islam, B., Kusunoki, S., Pardo, C. A., Reisin, R., Sejvar, J. J., Shahrizaila, N., Soares, C., Umapathi, T., Wang, Y., Yiu, E. M., Willison, H. J. & 1 others, , Nov 1 2019, In : Nature Reviews Neurology. 15, 11, p. 671-683 13 p.Research output: Contribution to journal › Article
Guidelines
Disease Outbreaks
Polynesia
Latin America
Immune System Diseases
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.Research output: Contribution to journal › Article
Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Safety
Drug-Related Side Effects and Adverse Reactions
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study
Van Schaik, I. N., Mielke, O., Bril, V., Van Geloven, N., Hartung, H. P., Lewis, R. A., Sobue, G., Lawo, J. P., Praus, M., Durn, B. L., Cornblath, D. R. & Merkies, I. S. J., Sep 1 2019, In : Neurology: Neuroimmunology and NeuroInflammation. 6, 5Research output: Contribution to journal › Article
Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Immunoglobulins
Safety
Recurrence
Hizentra